Disposition of ethmozine in cerebrospinal fluid and plasma of rabbits

  • K. Chan
  • J. M. Yang
  • M. K. Wai
  • W. D. Jiang
Original Papers


The concentration — time profiles of ethmozine, a newly introduced anti-arrhythmic drug, in the cerebrospinal fluid (CSF) and plasma of six rabbits (New Zealand white rabbits of both sexes, 4.0–5.0 Kg) were studied after intravenous bolus administration. CSF samples at various intervals were obtained while the animal was lightly anaesthetized with intravenous thiopentone (40 mg Kg−1 ) and blood samples at other intervals were taken while the animal was conscious. Blood samples (1 ml) were collected from the implanted cannula of the ear artery while CSF samples (0.3 ml) were obtained from the cisterna magna. The plasma concentrations of ethmozine in six rabbits declined rapidly after intravenous injection for up to 30 min. then slowly over 12 h. Using non-compartmental analysis, the mean ( ± S.E.M.) elimination half-life, mean residence time, plasma clearance and volume of distribution at steady state were 13.9±9.2h, 19.9±13.4 h, 2.3 Lh−1 and 26.8±7.9 L respectively. The mean CSF-plasma concentration ratios for ethmozine at 0,5, 1.0, 2.0, 4.0, 8.0 and 12.0 h were 0.17, 0.14, 0.16, 0.16, 0.23 and 0.22 respectively. The results suggest that ethmozine is able to penetrate into the CSF from the general circulation and this may be related to its adverse effects on the central nervous system.

Key words

Ethmozine concentration — time in CSF and plasma CSF-plasma concentration ratio 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Danilo P., Langan W.B., Rosen M.R., (1977): Effects of the phenothiazine analog EN-313, on ventricular arrththmias in the dog. Eur J Pharmacol 45: 127–139.CrossRefPubMedGoogle Scholar
  2. 2.
    Morganroth J., Pearlman A.S., Dunkman W.B. (1979): Ethmozine: A new antiarrththmic agent developed in the USSR, efficacy and tolerance. Am Heart J 98: 621–628.CrossRefPubMedGoogle Scholar
  3. 3.
    Chazov E.I., Shugushev K.K., Rosenshtraukh L.V. (1984): Ethmozine I. Effects of intravenuos drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome. Am Heart J 108: 475–482.CrossRefPubMedGoogle Scholar
  4. 4.
    Chazov E.I., Rosenshtraukh L.V., Shugushev K.K. (1984): Ethmozine II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia. Am Heart J 108: 483.CrossRefPubMedGoogle Scholar
  5. 5.
    Pratt C.M., Yepsen S.C., Taylor A.A. (1983): Ethmozine suppression of single and repetitine ventricular premature depolarizations during therapy: Documentation of efficacy and long term safety. Am Heart J 106: 85–91.CrossRefPubMedGoogle Scholar
  6. 6.
    Pratt C.M., Wierman A., Seals A.A. (1986): Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo — controlled prospective long — term clinical trial. Circulation 73: 718–726.PubMedGoogle Scholar
  7. 7.
    Yang J.M., Jiang W.D., Zhu J.R., Chen Y., Li Z.S., Chen Q.C., Wang Y.P. (1986): The determination of plasma concentration of ethmozine by HPLC and a pharmacokinetic study on ethmozine in normal subjects. Chin J Clin Pharmacol 2: 74–82.Google Scholar
  8. 8.
    Jiang W.D., Zhu J.R., Yang J.M., (1986): On the kinetics and dynamics of ethmozine in healthy subjects. Chin J Physiol Sei 2: 209–218.Google Scholar
  9. 9.
    Michelson E.L. and Dreifur L.S. (1988): Newer anti-arrhythmic drugs, Ethmozine. Med Clin North Am 72: 286–288.Google Scholar
  10. 10.
    Chan K., Wong C.L. and Wai M.K. (1986): Anti-tuberculous drug penetration into cerebrospinal fluid in a rabbit model. Asia Pacific J Pharmacol 1: 41–45.Google Scholar
  11. 11.
    Yang J.M., Chan K., Wai M.K.J, and Jiang W.D (1989): The physicochemical properties, distribution characteristics and CSF penetration of moricizine. Neuroscience Lett Suppl. 35: S61.Google Scholar
  12. 12.
    Martensson E., Nyberg G and Axelsson R. (1980): Thioridazine and thioridazine metabolites in cerebrospinal fluid in psychiatric patients. In: Usdin E., Eckert H and Forrest I S, Eds. Phenothazines and structurally related drugs: Basic and clinical studies. New York: Elsevier North Holland Inc. 173–176.Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • K. Chan
    • 1
  • J. M. Yang
    • 2
  • M. K. Wai
    • 1
  • W. D. Jiang
    • 2
  1. 1.Department of Pharmacology, Faculty of MedicineThe Chinese University of Hong KongShatin, N.T.Hong Kong
  2. 2.Department of Pharmacology, Faculty of Basic Medical SciencesShanghai Medical UniversityShanghaiP.R.C.

Personalised recommendations